HP Arize 3D Orthotics for Planar Fasciitis

Overview

Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.

Full Title of Study: “Comparing Efficacy Between Traditionally Fabricated Foot Orthotics and the HP Arize 3D Printed Foot Orthotics”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 30, 2023

Detailed Description

Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. Approximately half of the people with foot pain do not consult a doctor due to cost, convenience, or insurance reasons. To this end, HP will implement an end-to-end system to provide 3D-printed custom orthotic inserts to patients in a fast and efficient manner via their podiatrist. The Arize Orthotic solution developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. The Arize Orthotic Solution leverages HP 3D Printing technology and aims to further HP's mission to create technology that makes life better for everyone, everywhere. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.

Interventions

  • Device: HP Arize 3D-Printed Orthotics
    • Custom 3D-printed orthotics manufactured by HP.
  • Device: Traditional Orthotics
    • Traditionally fabricated custom orthotics manufactured by a local supplier.

Arms, Groups and Cohorts

  • Experimental: HP Arize 3D-Printed Orthotics
    • Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
  • Active Comparator: Traditional Orthotics
    • Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.

Clinical Trial Outcome Measures

Primary Measures

  • Patient-reported compliance and satisfaction with orthotics.
    • Time Frame: 8 weeks
    • Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this assessment.

Secondary Measures

  • Patient-reported secondary site pain following implementation of orthotics.
    • Time Frame: 8 weeks
    • Patient-reported secondary site pain for patients wearing either traditionally fabricated or 3D-printed orthotics will be assessed at the time of consent, 4 weeks, and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey asks patients to provide a pain score and function score for 11 locations on the body. Scores range from 0 to 100, with 0 being no pain or no limitation to physical function, and 100 being the worst pain possible or complete limitation to physical function.

Participating in This Clinical Trial

Inclusion Criteria

  • At least 18 years of age – Diagnosis of plantar fasciitis – Access to methods of electronic communication (i.e., email) Exclusion Criteria:

  • Previously prescribed and/or used orthotic inserts – Requires additional bracing of the lower leg – Diagnosis of neuropathy, acute fracture, or stress fracture – Pregnant women – Non-English speakers – Medicare patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Prisma Health-Midlands
  • Collaborator
    • Hewlett-Packard (HP)
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.